John Francis

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag et al. · Blood · 2011 · 480 citations · Full text

Medicine, Hematology, Pharmacology +14

Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454

Shaker A. Mousa, Mildred Amaya, Susan Blaydes et al. · Thrombosis and Haemostasis · 2003 · 137 citations

Medicine, Oncology, Pharmacology +15

CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study

Anthony Shock, Linda C. Burkly, Ian Wakefield et al. · Arthritis Research & Therapy · 2015 · 107 citations · Full text

Life Sciences, Hematology, Immunology +13

Reference Range Determination for Whole-Blood Platelet Aggregation Using the Multiplate Analyzer

Ellinor I.B. Peerschke, Donna D. Castellone, An K. Stroobants et al. · American Journal of Clinical Pathology · 2014 · 62 citations · Full text

Medicine, Hematology, Pharmacology +17

Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes

Douglas MacDonald, Joel Martin, Kathir Muthusamy et al. · Angiogenesis · 2016 · 44 citations · Full text

Medicine, Ophthalmology, Pharmacology +17